APS

Aptose Bio

• Dow Jones·11/19/2025 06:30

  *Aptose Biosciences: Expect Shares to Be Delisted Following Transaction >APS.T

• Dow Jones·11/19/2025 06:30

  *Aptose Biosciences: Hanmi Owns 19.93% of Aptose, to Acquire All Shares Not Currently Owned or Controlled >APS.T

• Dow Jones·11/19/2025 06:29

  *Aptose Biosciences: Entered Agreement for Acquisition by Hanmi Pharmaceutical >APS.T

• Dow Jones·11/13/2025 22:01

  *Aptose Biosciences 3Q Loss $5.12M >APS.T

• Dow Jones·06/17/2025 12:26

  Aptose Gets Advance From Chairman and CEO, Warns of Need for Funding

• Dow Jones·05/08/2025 11:01

  *Aptose Biosciences 1Q Loss/Shr $2.61 >APS.T

• Dow Jones·04/01/2025 21:08

  *News On Aptose Biosciences Inc. (APTO) Now Under APS.T

• Dow Jones·04/01/2025 19:15

  Aptose Biosciences' Shares Tumble Ahead of Nasdaq Delisting

• Dow Jones·03/28/2025 17:57

  Aptose Biosciences Is Maintained at Buy by HC Wainwright & Co.

• Dow Jones·03/28/2025 17:57

  Aptose Biosciences Price Target Raised to $6.00/Share From $2.00 by HC Wainwright & Co.

• Dow Jones·03/28/2025 12:03

  *Aptose Biosciences FY24 Loss $25.4M >APTO

• Dow Jones·03/28/2025 12:01

  Press Release: Aptose Reports Year End 2024 Results and Corporate Highlights

• Dow Jones·03/28/2025 12:01

  Press Release: Aptose Reports Year End 2024 -2-

• Dow Jones·02/18/2025 21:33

  *Aptose Announces 1-for-30 Reverse Shr Split

• Dow Jones·02/12/2025 17:05

  Aptose Biosciences Price Target Maintained With a $2.00/Share by HC Wainwright & Co.